COVID-19: The Essentials of Prevention and Treatment

By Jie-Ming Qu, Bin Cao and Rong-Chang Chen

COVID-19: The Essentials of Prevention and Treatment elaborates on the ethology, pathogenesis, epidemiology, clinical characteristics, treatment principles, rehabilitation and prevention, and prevention and control measures for COVID-19. Aimed at healthcare workers, and written to be a practical guide, six chapters cover the following aspects of COVID-19: respiratory viruses; pathogenesis; case definitions and diagnosis; treatment; prevention and disease control; and prospects for the management and research of respiratory virus infections. This book gives first-hand information on the prevention, control, diagnosis and treatment of COVID-19.COVID-19 was recognized as a pandemic in March 2020 by the World Health Organization. It is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Physicians working in China, particularly where the outbreak was first identified in Wuhan, have built up knowledge of prevention and control measures, and diagnosis and treatment of this disease. These insights are now globally relevant. The authors of this book are senior physicians specializing in respiratory diseases, pulmonary diseases and critical care medicine, and are all clinical and scientific research experts working in China, with particular experience in Wuhan.

• Describes the prevention, control, diagnosis and treatment of COVID-19
• Offers practical guidance to healthcare professionals for COVID-19
• Gives clinical insights in a question and answer format
• Details first-hand experience in Chinese cities during the initial outbreak
• Presents insights that healthcare professionals need to prevent, diagnose, and treat COVID-19

• Language: English
• Publisher: Elsevier Science
• Release date: Oct 22, 2020
• ISBN: 9780128242513

Jie-Ming Qu

Jie-Ming Qu is Chief Physician of Pulmonary Diseases and Critical Care Medicine, and Director of the Institute of Respiratory Diseases, at the Medical school of Shanghai Jiao-Tong University, in China. He is also President of the Chinese Thoracic Society (CTS) and Head of the CTS pulmonary infection group, among other key positions. He has published widely, including on the initial outbreak of the 2019 novel coronavirus. See, for example:

Book preview

China)

Prologue

Jie-ming Qu, President, Chinese Thoracic Society

Chen Wang, President, Chinese Association of Chest Physicians

In late 2019 and early 2020, several cases of unexplained pneumonia with fever, cough, fatigue, and/or respiratory distress as the main symptoms appeared in Wuhan, China, within a short time. It was determined that the disease was caused by a new coronavirus—2019 novel coronavirus (2019-nCoV)—and the disease was correspondingly named 2019 coronavirus disease (COVID-19). In the early stage of the epidemic, information on the epidemiological characteristics of COVID-19, clinical treatment options, and protection of medical personnel was rapidly changing and confusing. Therefore, the Chinese Thoracic Society and Chinese Association of Chest Physicians collected and followed up on questions of close concern to frontline medical personnel, and initiated a series of lectures to answer these questions on the Respiratory Community platform. The series of 20 lectures brought together experts in the field of respiratory and critical care medicine led by academician Chen Wang, Professor Jie-ming Qu, and experts in other professional fields closely related to the prevention and control of the epidemic, such as Professor Guang Zeng from the Chinese Center for Disease Control and Prevention.

Looking back at the fight against epidemics in China, we can see that with the accumulation of data, the understanding of COVID-19 has become more and more in-depth and comprehensive; accordingly, the prevention and control measures and treatment protocols have been continuously adjusted and improved. In order to reproduce realistically our understanding of COVID-19 and to summarize the prevention and control experience, this book presents the highlights of the lecture series in a question-and-answer format for the benefit of medical staff and readers alike. To date, our understanding of COVID-19 is still relatively superficial, new knowledge and technologies are still being enriched, and the fight against the epidemics has entered a new phase. It is believed that the dynamic perspective on emerging diseases, especially acute respiratory infectious diseases with significant socioeconomic impact, will also shed light on future prevention and control